Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹2530.00

prior close

₹2450.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.4%-3.4% vs market

Pharmaceuticals peers, median of 147sector-0.1%-3.6% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Midcap 150 and 3.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.2

10m

+1.0

15m

+0.9

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7-0.4-3.4-0.1-3.6

Next day

-4.2+0.2-4.4-0.3-3.9

-4.2+0.8-4.9-0.0-4.1

-3.0+1.0-4.0+0.2-3.1

-2.2+1.0-3.2+0.1-2.3

-2.8+1.6-4.4+0.5-3.2

-4.7+2.0-6.7-0.2-4.5

15d

-5.7+3.3-9.0+1.4-7.1

-9.1+2.6-11.7-2.7-6.4

+5.3+5.1+0.3+1.4+3.9

+3.1+2.9+0.2-1.0+4.1

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma Limited has submitted its audited financial results for the quarter and full year ended March 31, 2025 to the stock exchange. This is a routine regulatory filing under listing obligations. The detailed numbers, including revenue, profit after tax, margins, and segment performance, would be available in the accompanying results PDF. Investors should refer to the full financial statement for actual performance metrics.

Likely market impact

This is a procedural disclosure; the actual stock and shareholder impact depends on the numbers in the full results, which the market will digest in the following trading sessions.